Skip to main content
SpringerLink
Log in

Procedural Management

  • Chapter
  • First Online:
Blepharitis

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 347 Accesses

Abstract

The standard treatment for blepharitis includes topical or systemic therapy to reduce inflammation, increase meibum flow, and reduce bacterial load. These therapies include warm compresses, eyelid scrubs, topical anti-inflammatory agents, topical antibiotics, and oral antibiotics. Due to the lack of a truly curative treatment for blepharitis, a primary goal of treatment is symptomatic relief. In some patients with severe disease, medical management is often insufficient, and recent research has been focused on developing advancements in the procedural treatments of blepharitis. This chapter highlights some of the innovative procedural treatments for meibomian gland disease and blepharitis. There is also a discussion of the surgical treatment of complications of blepharitis such as trichiasis and distichiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Maskin SL. Intraductal Meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea. 2010;29:1145–52.

    Article  PubMed  Google Scholar 

  2. Maskin SL, Alluri S. Intraductal meibomian gland probing: background, patient selection, procedure, and perspectives. Clin Ophthalmol. 2019;13:1203–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Maskin SL, Alluri S. Expressible meibomian glands have occult fixed obstructions: findings from meibomian gland probing to restore Intraductal integrity. Cornea. 2019;38:8.

    Article  Google Scholar 

  4. Wladis EJ. Intraductal Meibomian gland probing in the management of ocular Rosacea. Ophthal Plast Reconstr Surg. 2012;28:416–8.

    Article  PubMed  Google Scholar 

  5. Syed ZA, Sutula FC. Dynamic intraductal meibomian probing: a modified approach to the treatment of obstructive meibomian gland dysfunction. Ophthal Plast Reconstr Surg. 2017;33:307–9.

    Article  PubMed  Google Scholar 

  6. Nakayama N, Kawashima M, Kaido M, Arita R, Tsubota K. Analysis of meibum before and after intraductal meibomian gland probing in eyes with obstructive meibomian gland dysfunction. Cornea. 2015;34:1206–8.

    Article  PubMed  Google Scholar 

  7. Sik Sarman Z, Cucen B, Yuksel N, Cengiz A, Caglar Y. Effectiveness of intraductal meibomian gland probing for obstructive meibomian gland dysfunction. Cornea. 2016;35:721–4.

    Article  PubMed  Google Scholar 

  8. Ma X. Lu Y. efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction. Cornea. 2016;35:725–30.

    Article  PubMed  Google Scholar 

  9. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31:396–404.

    Article  PubMed  Google Scholar 

  10. Godin MR, Gupta PK, Kim T. The “eyelid facial”: a review of meiboman gland heat treatments LipiFlow, MiBo Thermoflo, and intense pulsed light. In: Dry eye dis Pract guide. Thorofare: Slack Incorporated; 2019. p. 209–16.

    Google Scholar 

  11. Schiffman RM. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615.

    Article  CAS  PubMed  Google Scholar 

  12. Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment: thermal pulsation treatment of dry eye. Clin Exp Ophthalmol. 2013;41:524–30.

    Article  PubMed  Google Scholar 

  13. Greiner JV. A single LipiFlow ® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37:272–8.

    Article  PubMed  Google Scholar 

  14. Hagen K, Bedi R, Blackie C, Christenson-Akagi KJ. Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. Clin Ophthalmol. 2018;12:161–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kenrick CJ, Alloo SS. The limitation of applying heat to the external lid surface: a case of recalcitrant meibomian gland dysfunction. Case Rep Ophthalmol. 2017;8:7–12.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Badawi D. A novel system, TearCare® , for the treatment of the signs and symptoms of dry eye disease. Clin Ophthalmol. 2018;12:683–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Badawi D. TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease. Clin Ophthalmol. 2019;13:189–98.

    Article  PubMed  PubMed Central  Google Scholar 

  18. O’Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30:166–78.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015;33:41–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Craig JP, Chen Y-H, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Investig Opthalmol Vis Sci. 2015;56:1965.

    Article  Google Scholar 

  21. Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90.

    Article  CAS  PubMed  Google Scholar 

  22. Connor CG, Choat C, Narayanan S, Kyser K, Rosenberg B, Mulder D. Clinical effectiveness of lid debridement with BlephEx treatment. Invest Ophthalmol Vis Sci. 2015;56:4440.

    Google Scholar 

  23. Connor CG, Narayanan S, Miller W. Reduction in inflammatory marker matrix metalloproteinase-9 following lid debridement with BlephEx. Invest Ophthalmol Vis Sci. 2017;58:498.

    Google Scholar 

  24. Murphy O, O’Dwyer V, Lloyd-McKernan A. The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis. Cont Lens Anterior Eye. 2018;41:77–82.

    Article  PubMed  Google Scholar 

  25. Perry H, Serniuk R. Conservative treatment of chalazia. Ophthalmology. 1980;87:218–21.

    Article  CAS  PubMed  Google Scholar 

  26. Bensimon G, Huang L, Nakra T, Schwarcz R, Mccann J, Goldberg R. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology. 2005;112:913–7.

    Article  Google Scholar 

  27. Pizzarello L, Jakobiec F, Hofeldt A, Podolsky M, Silvers D. Intralesional corticosteroid therapy of chalazia. Am J Ophthalmol. 1978;85:818–21.

    Article  CAS  PubMed  Google Scholar 

  28. Watson A, Austin D. Treatment of chalazions with injection of a steroid suspension. Br J Ophthalmol. 1984;68:833–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Thomas E, Laborde R. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a Chalazion. Ophthalmology. 1986;93:405–7.

    Article  CAS  PubMed  Google Scholar 

  30. Aycinena ARP, Achiron A, Paul M, Burgansky-Eliash Z. Incision and curettage versus steroid injection for the treatment of chalazia: a meta-analysis. Ophthal Plast Reconstr Surg. 2016;32:220–4.

    Article  PubMed  Google Scholar 

  31. Park J, Chang M. Eyelid fat atrophy and depigmentation after an intralesional injection of triamcinolone acetonide to treat chalazion. J Craniofac Surg. 2017;28:e198–9.

    Article  PubMed  Google Scholar 

  32. Shiramizu KM, Kreiger AE, McCannel CA. Severe visual loss caused by ocular perforation during chalazion removal. Am J Ophthalmol. 2004;137:204–5.

    Article  PubMed  Google Scholar 

  33. Hosal BM, Zilelioglu G. Ocular complication of Intralesional corticosteroid injection of a Chalazion. Eur J Ophthalmol. 2003;13:798–9.

    Article  CAS  PubMed  Google Scholar 

  34. Yagci AP, Egrilmez S, Sahbazov C, Ozbek S. Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection. Ophthal Plast Reconstr Surg. 2008;24:55–7.

    Article  PubMed  Google Scholar 

  35. Papalkar D, Francis IC. Injections for chalazia? Ophthalmology. 2006;113:355–6. author reply 356-357

    Article  PubMed  Google Scholar 

  36. Ben Simon GJ, Rosen N, Rosner M, Spierer A. Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia: a prospective, randomized study. Am J Ophthalmol. 2011;151:714–718.e1.

    Article  CAS  PubMed  Google Scholar 

  37. Kezirian G. Treatment of localized trichiasis with radiosurgery. Ophthal Plast Reconstr Surg. 1933;9:260–6.

    Article  Google Scholar 

  38. Ferreira IS, Bernardes TF, Bonfioli AA. Trichiasis. Semin Ophthalmol. 2010;25:66–71.

    Article  PubMed  Google Scholar 

  39. Sakarya Y, Sakarya R, Yildihm A. Electrolysis treatment of trichiasis by using ultra-fine needle. Eur J Ophthalmol. 2010;20:664–8.

    Article  PubMed  Google Scholar 

  40. Sullivan J, Beard C, Bullock J. Cryosurgery for the treatment of trichiasis. Am J Ophthalmol. 1976;82:117–21.

    Article  CAS  PubMed  Google Scholar 

  41. Majekodunmi S. Cryosurgery in treatment of trichiasis. Br J Ophthalmol. 1982;66:337–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Berry J. Recurrent trichiasis: treatment with laser photocoagulation. Ophthalmic Surg. 1979;10:36–8.

    CAS  PubMed  Google Scholar 

  43. Bartley G, Lowry J. Argon laser treatment of trichiasis. Am J Ophthalmol. 1992;113:71–4.

    Article  CAS  PubMed  Google Scholar 

  44. Moore J, De Silva SR, O’Hare K, Humphry RC. Ruby laser for the treatment of trichiasis. Lasers Med Sci. 2009;24:137–9.

    Article  PubMed  Google Scholar 

  45. Pham RTH, Biesman BS, Silkiss RZ. Treatment of trichiasis using an 810-nm diode laser: an efficacy study. Ophthal Plast Reconstr Surg. 2006;22:445–7.

    Article  PubMed  Google Scholar 

  46. McCracken MS, Kikkawa DO, Vasani SN. Treatment of trichiasis and distichiasis by eyelash trephination. Ophthal Plast Reconstr Surg. 2006;22:349–51.

    Article  PubMed  Google Scholar 

  47. Ferraz LC, Meneghim RL, Galindo-Ferreiro A, Wanzeler AC, Saruwatari MM, Satto LH, et al. Outcomes of two surgical techniques for major trichiasis treatment. Orbit. 2018;37:36–40.

    Article  PubMed  Google Scholar 

  48. Moosavi AH, Mollan SP, Berry-Brincat A, Abbott J, Sutton GA, Murray A. Simple surgery for severe trichiasis. Ophthal Plast Reconstr Surg. 2007;23:296–7.

    Article  PubMed  Google Scholar 

  49. Chi MJ, Park MS, Nam DH, Moon HS, Baek SH. Eyelid splitting with follicular extirpation using a monopolar cautery for the treatment of trichiasis and distichiasis. Graefes Arch Clin Exp Ophthalmol. 2007;245:637–40.

    Article  PubMed  Google Scholar 

  50. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107–26.

    Article  PubMed  Google Scholar 

  51. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1–14.

    Article  PubMed  Google Scholar 

  52. Jehangir N, Bever G, Mahmood SMJ, Moshirfar M. Comprehensive review of the literature on existing punctal plugs for the management of dry eye disease. J Ophthalmol. 2016;2016:1–22.

    Article  CAS  Google Scholar 

  53. Tong L, Beuerman R, Simonyi S, Hollander DA, Stern ME. Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye. Ocul Surf. 2016;14:233–41.

    Article  PubMed  Google Scholar 

  54. Song JS, Woo IH, Eom Y, Kim HM. Five misconceptions related to punctal plugs in dry eye management. Cornea. 2018;1:S58.

    Article  Google Scholar 

  55. American Academy of Ophthalmology. Punctal occlusion for the dry eye. Ophthalmology. 1997;104:1521–4.

    Article  Google Scholar 

  56. Murube J, Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol. 1996;40:463–80.

    Article  CAS  PubMed  Google Scholar 

  57. Liu D. Surgical punctal occlusion: a prospective study. Br J Ophthalmol. 2002;86:1031–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Compliance with Ethical Requirements

The authors of this chapter do not have any conflicts of interest to report. The writing of this chapter did not involve carrying out any studies with human participants or animals performed by any of the authors.

Author information

Authors and Affiliations

  1. University of Chicago Medical Center, Department of Ophthalmology and Visual Science, Chicago, IL, USA

    Megan Silas & Hassan Shah

  2. University of Chicago Pritzker School of Medicine, Chicago, IL, USA

    Johnathan Jeffers

Authors
  1. Megan Silas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johnathan Jeffers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hassan Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hassan Shah .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology & Visual Science, University of Chicago Medical Center, Chicago, IL, USA

    Asim V. Farooq

  2. Department of Ophthalmology & Visual Science, University of Chicago Medical Center, Chicago, IL, USA

    James J. Reidy

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Silas, M., Jeffers, J., Shah, H. (2021). Procedural Management. In: Farooq, A.V., Reidy, J.J. (eds) Blepharitis. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-65040-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-65040-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-65039-1

  • Online ISBN: 978-3-030-65040-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation